Literature DB >> 20516728

Serotonin receptor 3A expression in normal and neoplastic B cells.

Andrea Rinaldi1, Anna Maria Chiaravalli, Michael Mian, Emanuele Zucca, Maria Grazia Tibiletti, Carlo Capella, Francesco Bertoni.   

Abstract

Chromosome 11q21-qter is a very gene-rich region and is often targeted by genomic aberrations in a variety of human cancers, including B cell lymphoid neoplasms. In order to identify genes which could be deregulated in diffuse large B cell lymphomas (DLBCL), we analyzed the expression levels of genes mapped on chromosome 11q21-qter across a series of publicly available DLBCL expression data sets. We identified HTR3A, the gene coding for 5-hydroxytryptamine receptor 3A, as the most frequently differentially expressed. Since HTR3A expression had not been previously characterized in normal and neoplastic B cells, we evaluated its expression by real-time PCR and by immunohistochemistry. The gene is expressed by B cells and it seems to be regulated during the mature B cell differentiation, being overexpressed during the germinal center phase. Lymphomas derived from germinal center B cells maintain the expression, with the level of expression varying among different patients. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20516728     DOI: 10.1159/000292646

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  12 in total

1.  Downregulation of 5-hydroxytryptamine receptor 3A expression exerts an anticancer activity against cell growth in colorectal carcinoma cells in vitro.

Authors:  Jian Tang; Zheng Wang; Jiahua Liu; Chao Zhou; Jinxian Chen
Journal:  Oncol Lett       Date:  2018-08-23       Impact factor: 2.967

Review 2.  5-HT and the immune system.

Authors:  Gerard P Ahern
Journal:  Curr Opin Pharmacol       Date:  2011-03-08       Impact factor: 5.547

3.  5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor.

Authors:  Amy S Newman; Nikolaos Batis; Gillian Grafton; Francesca Caputo; Catherine A Brady; Jeremy J Lambert; John A Peters; John Gordon; Keith L Brain; Andrew D Powell; Nicholas M Barnes
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

Review 4.  Immunomodulatory effects mediated by serotonin.

Authors:  Rodrigo Arreola; Enrique Becerril-Villanueva; Carlos Cruz-Fuentes; Marco Antonio Velasco-Velázquez; María Eugenia Garcés-Alvarez; Gabriela Hurtado-Alvarado; Saray Quintero-Fabian; Lenin Pavón
Journal:  J Immunol Res       Date:  2015-04-19       Impact factor: 4.818

Review 5.  The Effects of Serotonin in Immune Cells.

Authors:  Nadine Herr; Christoph Bode; Daniel Duerschmied
Journal:  Front Cardiovasc Med       Date:  2017-07-20

6.  Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine.

Authors:  Abbie G Anderson; Cullen B Gaffy; Joshua R Weseli; Kelly L Gorres
Journal:  Viruses       Date:  2019-05-17       Impact factor: 5.048

7.  The Antidepressant Mirtazapine Rapidly Shifts Hepatic B Cell Populations and Functional Cytokine Signatures in the Mouse.

Authors:  Wagdi Almishri; Rachelle P Davis; Abdel-Aziz Shaheen; Mohammed O Altonsy; Craig N Jenne; Mark G Swain
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

Review 8.  The Brain-Skin Connection and the Pathogenesis of Psoriasis: A Review with a Focus on the Serotonergic System.

Authors:  Ana M Martins; Andreia Ascenso; Helena M Ribeiro; Joana Marto
Journal:  Cells       Date:  2020-03-26       Impact factor: 6.600

9.  Increasing serotonin bioavailability alters gene expression in peripheral leukocytes and lymphoid tissues of dairy calves.

Authors:  M G Marrero; S L Field; A L Skibiel; B Dado-Senn; J P Driver; J Laporta
Journal:  Sci Rep       Date:  2020-06-16       Impact factor: 4.379

Review 10.  Critical Neurotransmitters in the Neuroimmune Network.

Authors:  Thomas Wesley Hodo; Maria Teresa Prudente de Aquino; Akiko Shimamoto; Anil Shanker
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.